We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.7B
AUM Growth
-$32.1M
(-0.06%)
Cap. Flow
-$1.71B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
1,757
New
32
Increased
448
Reduced
504
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$159M |
| 2 |
Uber
UBER
|
+$127M |
| 3 |
Broadcom
AVGO
|
+$118M |
| 4 |
Humana
HUM
|
+$89.3M |
| 5 |
KKR & Co
KKR
|
+$71.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$171M |
| 2 |
Apple
AAPL
|
+$145M |
| 3 |
Merck
MRK
|
+$107M |
| 4 |
Nike
NKE
|
+$95.7M |
| 5 |
Mastercard
MA
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.24% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.51% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
BridgeBio Pharma
BBIO
$16.5B
| $41.7M | 0.08% |
1,646,202
+506,845
| +44% | +$13.9M |
|
202
Extra Space Storage
EXR
$31.2B
| $41.5M | 0.08% |
267,101
-11,228
| -4% | -$1.64M |
|
203
Ecolab
ECL
$75.6B
| $40M | 0.07% |
168,123
-6,199
| -4% | -$1.43M |
|
204
Lamb Weston
LW
$6.82B
| $40M | 0.07% |
475,694
+127,281
| +37% | +$10.9M |
|
205
BWX Technologies
BWXT
$16B
| $38.2M | 0.07% |
402,245
+64,990
| +19% | +$6.03M |
|
206
Snowflake
SNOW
$92.9B
| $38M | 0.07% |
281,528
-68,488
| -20% | -$10.1M |
|
207
Neurocrine Biosciences
NBIX
$17.7B
| $37.5M | 0.07% |
272,613
+117,902
| +76% | +$16.2M |
|
208
Target
TGT
$62.1B
| $37.1M | 0.07% |
250,780
-43,171
| -15% | -$6.79M |
|
209
Becton Dickinson
BDX
$43.1B
| $36.6M | 0.07% |
156,408
-15,297
| -9% | -$3.6M |
|
210
HealthEquity
HQY
$7.91B
| $35.7M | 0.07% |
414,019
+73,427
| +22% | +$5.93M |
|
211
Sarepta Therapeutics
SRPT
$1.66B
| $35.6M | 0.07% |
225,328
+38,090
| +20% | +$4.89M |
|
212
T-Mobile US
TMUS
$193B
| $35.3M | 0.06% |
200,545
-7,585
| -4% | -$1.27M |
|
213
Trade Desk
TTD
$8.13B
| $35.3M | 0.06% |
361,387
-568,608
| -61% | -$51.3M |
|
214
DexCom
DXCM
$27.6B
| $35.2M | 0.06% |
310,746
-27,067
| -8% | -$3.42M |
|
215
Vaxcyte
PCVX
$7.89B
| $34.9M | 0.06% |
462,682
-13,018
| -3% | -$886K |
|
216
DoorDash
DASH
$75.3B
| $34.8M | 0.06% |
319,616
-260,983
| -45% | -$31.4M |
|
|
WNS
217
DELISTED
WNS Holdings
WNS
| $34.4M | 0.06% |
655,066
-191,768
| -23% | -$9.49M |
|
218
Vertiv
VRT
$112B
| $34.4M | 0.06% |
396,978
+102,864
| +35% | +$9.36M |
|
219
Essential Utilities
WTRG
$11.2B
| $34.4M | 0.06% |
920,253
-13,110
| -1% | -$486K |
|
220
3M
MMM
$89B
| $34.3M | 0.06% |
335,895
+186,674
| +125% | +$18.2M |
|
221
Eversource Energy
ES
$28.2B
| $33.9M | 0.06% |
596,911
+80,541
| +16% | +$4.77M |
|
222
PNC Financial Services
PNC
$100B
| $33.8M | 0.06% |
217,239
-58,587
| -21% | -$9.08M |
|
223
Teradyne
TER
$54.8B
| $33.5M | 0.06% |
225,964
-12,785
| -5% | -$1.62M |
|
224
CBRE Group
CBRE
$40.8B
| $33.5M | 0.06% |
376,013
-26,498
| -7% | -$2.35M |
|
|
BPMC
225
DELISTED
Blueprint Medicines
BPMC
| $33M | 0.06% |
306,316
-13,212
| -4% | -$1.32M |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Ensign Peak Advisors held 1,757 positions worth $54.7B, down 0.06% from $54.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ensign Peak Advisors withdrew a net $1.71B in Q2 2024, closing 45 positions and reducing 504 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $63.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ensign Peak Advisors opened a new position in JFrog worth $30.1M.
- Ensign Peak Advisors's largest Q2 2024 buy was JFrog: 801,556 shares worth $30.1M.
- Ensign Peak Advisors added most to GE Aerospace in Q2 2024, an estimated $159M increase.
- Ensign Peak Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $171M.
- Ensign Peak Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $63.5M.
- Ensign Peak Advisors's ten largest holdings make up 33% of its $54.7B portfolio in Q2 2024.
- Ensign Peak Advisors opened 32 new positions and closed 45 in Q2 2024.
- Ensign Peak Advisors's portfolio value fell 0.06% quarter-over-quarter to $54.7B.
Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.